SLXN
insider transactionsSilexion Therapeutics Corp — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 365d
-22.8K
0 buy · 22.8K sell
Net value · 365d
-$31.0K
$0 in · $31.0K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
1
0 buy · 22.8K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Grant·A
CSO and CDO
$0
6.0K sh
Own +215%
-
Grant·A
CFO and Secretary
$0
7.5K sh
Own +150%
-
Grant·A
Ilan Hadar KEY
Chairman and CEO
$0
10.0K sh
Own +153%
-
Sell·S
CSO and CDO
$31.0K
22.8K sh · $1.36
Own -45%
-
Grant·A
CSO and CDO
$0
49.7K sh
Own +5069%
-
Grant·A
Director
$0
8.9K sh
Own New
-
Grant·A
Director
$0
7.6K sh
Own +1146%
-
Grant·A
Director
$0
10.7K sh
Own New
-
Grant·A
Director
$0
9.1K sh
Own +56%
-
Grant·A
CFO and Secretary
$0
49.7K sh
Own +11840%
-
Grant·A
Ilan Hadar KEY
Chairman and CEO
$0
64.3K sh
Own +5740%
-
Grant·A
Director
$0
10.7K sh
Own New
-
Grant·A
Director
$0
9.1K sh
Own +800%
-
Grant·A
Director
$0
10.7K sh
Own New
-
Grant·A
Director
$0
9.1K sh
Own +835%
-
Grant·A
Director
$0
10.7K sh
Own New
-
Grant·A
Director
$0
9.1K sh
Own +56%
-
Grant·A
Ilan Levin / Moringa Sponsor, LP
Director, 10% Owner
$1.8M
450.0K sh · $4.00
Own +6456%
-
Other·J
Ilan Levin / Moringa Sponsor, LP
Director, 10% Owner
$0
935 sh
-
Other·J
Ilan Levin / Moringa Sponsor, LP
Director, 10% Owner
$0
5.5K sh
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 4, 2026 | Mitchell Shirvan | Grant A | 6.0K | $0 |
| Jun 4, 2026 | Hadar Mirit Horenshtein KEY | Grant A | 7.5K | $0 |
| Jun 4, 2026 | Ilan Hadar KEY | Grant A | 10.0K | $0 |
| Mar 26, 2026 | Mitchell Shirvan | Sell S | 22.8K | $31.0K |
| Feb 20, 2026 | Mitchell Shirvan | Grant A | 49.7K | $0 |
| Feb 20, 2026 | Amnon Peled | Grant A | 8.9K | $0 |
| Feb 20, 2026 | Amnon Peled | Grant A | 7.6K | $0 |
| Feb 20, 2026 | Avner Lushi | Grant A | 10.7K | $0 |
| Feb 20, 2026 | Avner Lushi | Grant A | 9.1K | $0 |
| Feb 20, 2026 | Hadar Mirit Horenshtein KEY | Grant A | 49.7K | $0 |
| Feb 20, 2026 | Ilan Hadar KEY | Grant A | 64.3K | $0 |
| Feb 20, 2026 | Ruth Alon | Grant A | 10.7K | $0 |
| Feb 20, 2026 | Ruth Alon | Grant A | 9.1K | $0 |
| Feb 20, 2026 | Dror Yosef Abramov | Grant A | 10.7K | $0 |
| Feb 20, 2026 | Dror Yosef Abramov | Grant A | 9.1K | $0 |
| Feb 20, 2026 | Shlomo Noy | Grant A | 10.7K | $0 |
| Feb 20, 2026 | Shlomo Noy | Grant A | 9.1K | $0 |
| Sep 15, 2025 | Ilan Levin / Moringa Sponsor, LP | Grant A | 450.0K | $1.8M |
| Aug 7, 2025 | Ilan Levin / Moringa Sponsor, LP | Other J | 935 | $0 |
| Aug 7, 2025 | Ilan Levin / Moringa Sponsor, LP | Other J | 5.5K | $0 |
About SLXN insider trading
This page tracks insider transactions for Silexion Therapeutics Corp (SLXN) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.